At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CD80, CD163 and CD206 Tissue Levels in Periodontal and Peri-implant Health and Disease
In Brief
An observational study for Peri-Implantitis and Periodontitis. Completed, enrolled 36 participants across 1 site.
Detailed Summary
Macrophage surface markers (CD80, CD163 and CD206) will be evaluated in periodontally healthy gingiva, healthy peri-implant mucosa, and periodontitis and peri-implantitis lesions.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeri-Implantitis, Periodontitis
CountriesTurkey (Türkiye)
CollaboratorsUniversity of Turku
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
Primary CompletionDec 2021
First PostedFeb 2022
TodayJul 2026
First PostedFeb 16, 2022
Enrollment StartMar 1, 2021
Primary CompletionDec 31, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.4 years ago